Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1282, 2009-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rosiglitazone: FDA must provide more than black box warning
Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. :
Access to resources
Recommend
Rosiglitazone meta-analysis: full impact on prescribing yet to be felt
Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. :
Neural tube defect rate unchanged despite folic acid supplementation
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :
By Wolffenbuttel B.H. Sels J-P. Huijberts M.S.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. :
By Barman Balfour J.A. Plosker G.L.
Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. :